OUS, The Norwegian Radium Hospital, Oslo, Norway
Mette Sprauten , Milada Cvancarova , Sophie D. Fossa , Marianne Brydoy , Hege Sagstuen Haugnes , Jan Oldenburg
C: n=570, (100%) |
S: n=69, (100%) |
RT: n=133, (100%) |
CT: n=109, (100%) |
|
---|---|---|---|---|
Pretreatment | ||||
<25% | 139 (24.4) | 39 (56.5) | 62 (46.6) | 42 (38.5) |
>75% | 141 (24.7) | 3 (4.3) | 18 (13.5) | 18 (16.5) |
OR(95%CI) | Referent (R) | 13.2 (4.0- 43.7) | 3.5 (2.0- 6.2) | 2.4 (1.3- 4.3) |
S 9 | ||||
<25% | 139 (24.4) | 28 (40.6) | 61 (45.9) | 59 (54.1) |
>75% | 141 (24.7) | 9 (13.0) | 12 (9.0) | 12 (11.0) |
OR(95%CI) | R | 3.2 (1.4- 7.0) | 5.2 (2.7- 10.0) | 5.0 (2.6- 9.7) |
S18 | ||||
<25% | 139 (24.4) | 26 (37.7) | 61 (45.9) | 67 (61.5) |
>75% | 141 (24.7) | 6 (8.7) | 9 (6.8) | 10 (9.2) |
OR(95%CI) | R | 4.4 (1.8- 11.0) | 6.9 (3.3- 4.4) | 6.8 (3.4- 13.7) |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2024 ASCO Genitourinary Cancers Symposium
First Author: Zuzana Orszaghova
2023 ASCO Annual Meeting
First Author: Santhanam Sundar
2021 Genitourinary Cancers Symposium
First Author: Davide Bimbatti
2023 ASCO Annual Meeting
First Author: Marcin W Wojewodzic